Introduction
============

As survival of very preterm infants improves, the effort to improve major morbidities and quality of life in those infants has become a hot topic in neonatology. Of the major morbidities, neurologic impairment is one of the most important problems and requires early detection and intervention. Early detection of neurologic problems in preterm infants is important because early therapeutic intervention has a positive effect on final neurologic outcome[@B1],[@B2].

Germinal matrix-intraventricular hemorrhage (IVH) is the most common variety of neonatal intracranial hemorrhage and is characteristic of the premature infant. It is well known that IVH is closely related to the mortality rate and neurological sequelae in premature infants[@B3].

Having no or mild IVH results in better outcomes than having a severe one. However, cranial ultrasonography, which is the screening procedure of choice for IVH, is limited in its ability to predict neurological sequelae.

In this study, we evaluated the early developmental status of very low birth weight (VLBW) infants with no or low-grade IVH (≤grade II), which is a major patient population of high-risk preterm infants. And we also tried to identify the perinatal morbidities affecting early neurodevelopmental outcome.

Materials and methods
=====================

1. Study subjects
-----------------

A retrospective review of medical records was performed for all infants who were treated in the neonatal intensive care units (NICU) of Korea University Medical Centers between 2006 and 2009. Fortynine VLBW infants (birth weight\<1,500 g) with no or low-grade IVH (≤grade II) were enrolled in this study. Gestational age and birth weight of the 49 infants were 28^+3^±2^+4^ weeks and 1,095±274 g, respectively. Demographic data of the subjects are shown in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

2. Assessment of neurodevelopment
---------------------------------

When subjects reached a corrected age of 12 months, one psychologist administered the Bayley Scales of Infant Development-II (BSID-II). BSID-II yielded scores for mental and psychomotor development with a standardization mean of 100 and standard deviation of 15 points. The mental developmental index (MDI) and psychomotor developmental index (PDI) were used as scales of cognition and motor development, respectively. Abnormal MDI or PDI were defined as scores of less than 85. Development was considered mildly impaired if scores were 70 to 84, moderately impaired if 55 to 69, and severely impaired if less than 55. Comparisons between the two groups with normal and abnormal developmental scores were performed, and correlations between developmental outcomes and perinatal morbidities were analyzed.

3. Definitions of perinatal morbidities
---------------------------------------

The protocol for IVH screening of VLBW infants in the NICU involved radiologists evaluating a cranial ultrasonogram within one week postnatally and every 2 to 4 weeks until the time of discharge from the NICU. The definition of IVH was based on the Papil grading system[@B4].

Respiratory distress syndrome was defined by the therapeutic instillation of surfactant, and patent ductus arteriosus (PDA) was defined by therapeutic injection of prostaglandin inhibitor or a ligation operation. Bronchopulmonary dysplasia (BPD) was defined as the need for supplemental oxygen support at a postmenstrual age of 36 weeks[@B5], and necrotizing enterocolitis was defined as Bell\'s stage II or greater[@B6]. Retinopathy of prematurity was defined as the need for therapeutic intervention, and sepsis was defined as a positive blood culture with clinical signs of sepsis.

4. Statistical analysis
-----------------------

Categorical data are presented as numbers (%), and continuous data as the mean±SD or median (25 to 75%). The χ^2^ or Fisher\'s exact test was used to compare categorical variables, and the Student\'s *t* test and the Mann-Whitney\'s rank sum *U* test were used to compare continuous variables in univariate analysis. IBM SPSS ver. 19.0 (IBM Co., Armonk, NY, USA) was used for the statistical analysis, and a *P* value of less than 0.05 was considered statistically significant. Multiple logistic regression was performed with significant factors identified in the univariate analysis.

Results
=======

1. Neurodevelopmental outcome
-----------------------------

Nineteen infants (38.8%) had normal scores of above 85 on both the MDI and PDI, and 14 infants (28.6%) had less than 85 on both the MDI and PDI. Distributions of MDI and PDI scores of all infants are shown in [Fig. 1](#F1){ref-type="fig"}.

### 1) Mental development

The mean MDI score of all 49 infants was 94±27. Thirty-five infants (71.4%) had normal MDI scores that were between 85 and 115. Fourteen infants (28.6%) had MDI scores of less than 85 and comprised the abnormal MDI group. Three (6.1%) had MDI scores of 70 to 84, suggesting mild impairment, and three (6.1%) had MDI scores of 55 to 69, suggesting moderate impairment. Eight (16.3%) had MDI scores of less than 55, suggesting severe impairment.

### 2) Motor development

The mean PDI score of all 49 infants was 81±19. Twenty infants (40.8%) had normal PDI scores that were between 85 and 115. Twenty-nine infants (59.2%) had PDI scores of less than 85 and comprised the abnormal PDI group. Fourteen (28.6%) had PDI scores of 70 to 84, suggesting mild impairment, and eight (16.3%) had PDI scores of 55 to 69, suggesting moderate impairment. Seven (14.3 %) had PDI scores of less than 55, suggesting severe impairment.

2. Perinatal morbidities affecting early neurodevelopmental outcome
-------------------------------------------------------------------

### 1) Comparison between groups with normal and abnormal mental development

Compared to the normal MDI group (n=35), the abnormal MDI group (n=14) were more often male and had a longer duration of hospitalization, higher prevalence of PDA and BPD, and more postnatal use of systemic steroids (*P*\<0.05) ([Table 3](#T3){ref-type="table"}). In the multiple logistic regression, male gender was the only statistically significant risk factor (odds ratio \[OR\], 17.1; 95% confidence interval (CI), 1.83 to 159.4; *P*=0.013) ([Table 4](#T4){ref-type="table"}).

### 2) Comparison between groups with normal and abnormal motor development

Compared to the normal PDI group (n=20), the abnormal PDI group (n=29) had a longer duration of hospitalization and higher prevalence of PDA (*P*\<0.05) ([Table 5](#T5){ref-type="table"}). In the multiple logistic regression, there was no statistically significant factor associated with abnormal PDI among the perinatal morbidities that was significant in the univariate analysis ([Table 4](#T4){ref-type="table"}).

### 3) Comparison between groups with normal and global impairment

Compared to normal infants (n=19), the infants with global mental and psychomotor impairment (n=14) were more often male and had a longer duration of hospitalization and more PDA and BPD (*P*\<0.05) ([Table 6](#T6){ref-type="table"}). In the multiple logistic regression, a longer duration of hospitalization was the only statistically significant risk factor (OR, 1.08; 95% CI, 1.004 to 1.156; *P*=0.038) ([Table 4](#T4){ref-type="table"}).

Discussion
==========

The purpose of this study was to objectively assess the early development of VLBW infants with no or mild IVH, which is a major patient population of high-risk preterm infants, and to identify the perinatal morbidities affecting early neurodevelopmental outcome. We observed that 62% of VLBW infants with no or mild IVH had impaired early development, and several perinatal factors, such as longer duration of hospitalization, male gender, the presence of PDA or BPD, and postnatal use of systemic steroids, were related to impaired early development. In particular, longer duration of hospitalization and male gender were the most important prognostic factors in the early development of VLBW infants with no or mild IVH.

In a previous report, 10 to 15% of surviving VLBW infants were diagnosed with neurologic problems, such as cerebral palsy and major psychomotor and cognitive deficits[@B7]. Although cranial ultrasonography is the screening procedure of choice for IVH, some reports suggest that over 50% of VLBW infants with cerebral palsy do not have intraventricular abnormalities detectable by ultrasonography[@B8]. Moreover, neurologic manifestations of cerebral palsy may not be apparent until the child is 2 to 3 years old[@B9].

Naturally, it is difficult to predict cognitive and motor functions in growing and developing infants, especially among expreterm infants with a mild degree of impairment. The later the assessment of neurodevelopment is performed, the more the findings approximate the final neurodevelopmental outcome. However, earlier recognition of developmental problems is important because early intervention for preterm infants with neurodevelopmental impairment may improve cognitive and neuromotor development[@B10],[@B11]. Therefore, the effort to detect early neurodevelopmental problems can be very important.

BSID is the gold standard for assessing motor and cognitive performance of preterm infants in many studies, despite some limitations[@B12],[@B13]. There are many studies that have evaluated the neurodevelopment of preterm infants with a variety of objectives at different time points. Hack et al.[@B14] reported that 67% and 39% of extremely low birth weight infants had MDI scores \<85 and \<70 at a corrected age of 20 months, respectively. Chuang et al.[@B15] reported that VLBW infants with subependymal cysts had a significantly lower psychomotor development index and were more likely than normal term infants to have motor developmental delay at a corrected age of 24 months. In this study, we performed the neurodevelopmental assessment at an earlier age, a corrected age of 12 months, and specifically focused on VLBW infants with no or mild IVH, which is a patient population that includes many high-risk preterm infants.

In this study, we used the BSID-II, which is an assessment tool with confirmed validity and objectivity that is recognized by most neonatologists, to evaluate the early neurodevelopment of VLBW infants with no or mild IVH[@B16]. Our study revealed that many of the infants had an abnormal neurodevelopmental status necessitating careful follow-up and early therapeutic intervention.

Our results also showed that a longer duration of hospitalization, male gender, the presence of PDA or BPD, and postnatal use of systemic steroids might be associated with abnormal neurodevelopmental outcomes. It has been reported that BPD, PDA, and postnatal use of systemic steroids are associated with adverse mental and psychomotor development[@B17]-[@B20].

Male gender is also known to be an independent risk factor for adverse mental and psychomotor development[@B21],[@B22].

In conclusion, over half of the VLBW infants with no or low grade IVH in our study had impaired early development at corrected age 12 months. Several perinatal factors, such as longer duration of hospitalization, male gender, the presence of PDA or BPD, and postnatal use of systemic steroids, were potential risk factors for impaired development. In particular, prolonged hospitalization and male gender were closely related factors. Therefore, male preterm infants who have prolonged hospitalizations require careful neurodevelopmental examination, even if the infants do not have a history of severe IVH.
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Patients\' Demographic Data-I
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^\*^Apgar score is expressed with median (25-75%).
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Patients\' Demographic Data-II
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PROM, premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia.
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Comparison of the Normal and Abnormal MDI Groups
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Values are presented as mean±SD, mean (range) or number (%).

MDI, mental developmental index; PROM, premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia.

^\*^Apgar score is expressed with median (25-75%).
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Multiple Regression Analysis for Determining Risk Factors of Abnormal Early Neurodevelopment
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Values are presented as odds ratio (95% confidence interval)/*P* value.

PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia.
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Comparison of the Normal and Abnormal PDI Groups
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Values are presented as mean±SD, mean (range) or number (%).

PDI, psychomotor developmental index; PROM, premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia.

^\*^Apgar score is expressed with median (25-75%).
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Comparison of the Normal Group and Global Impairment Group
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Values are presented as mean±SD, mean (range) or number (%).

PROM, premature rupture of membrane; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia.
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